Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-02-06T01:58:34.685Z Has data issue: false hasContentIssue false
  • English
  • Français

A Clinical Trial of Imipramine (“Tofranil”) on Depressed Patients

Published online by Cambridge University Press:  08 February 2018

W. Ross Ashby  and
G. H. Collins
W. Ross Ashby
Affiliation:
University of Illinois, Urbana, Illinois, U.S.A.
G. H. Collins
Affiliation:
Kingsway Hospital, Derby
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Recently many new anti-depressive drugs have flooded the market, the objective being initially to assist and finally to replace E.C.T. as the treatment of choice for depressive states. One such preparation is Tofranil (N-(γ-Dimethyl-aminopropyl)-iminodibenzyl hydrochloride or imipramine). It was first favourably reported on by Azima (1) and Kuhn (2).

Type
Original Articles
Information
Journal of Mental Science , Volume 107 , Issue 448 , May 1961 , pp. 547 - 551
Copyright
Copyright © Royal College of Psychiatrists, 1961 

References

1 Azima, H., and Vispo, R. H., Amer. J. Psychiat., 1958, 115, 245.CrossRefGoogle Scholar
2 Kuhn, R., ibid., 1958, 115, 459.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.